US Broker Ratings

MeiraGTx Holdings plc (MGTX) Stock Analysis: A Biotech Gem with a 236% Upside Potential

MeiraGTx Holdings plc (NASDAQ: MGTX) is capturing significant attention from the investment community due to its promising outlook in the biotechnology industry. With a market capitalization..

CorMedix Inc. (CRMD) Investor Outlook: Analyzing a Potential 103% Upside

CorMedix Inc. (NASDAQ: CRMD), a pioneering entity in the biotechnology sector, has garnered significant investor attention with its ambitious pipeline aimed at addressing life-threatening diseases. As..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Unveiling a 42% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH) is capturing investor attention with its considerable potential upside of 42.45%, according to analysts’ average target prices. As a biopharmaceutical company,..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a Biotech Underdog with Nearly 93% Upside Potential

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) has emerged as a compelling player in the biotechnology sector, focusing on pioneering gene therapies for rare and life-threatening diseases. With..

COMPASS Pathways Plc (CMPS): Investor Outlook with a 143% Potential Upside

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology company focusing on mental health treatment, is capturing the attention of investors with its remarkable potential upside of..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Harnessing a 47.67% Potential Upside Amidst Strong Buy Ratings

OrthoPediatrics Corp. (NASDAQ: KIDS), a niche player in the healthcare sector specializing in pediatric orthopedic medical devices, is drawing considerable attention from investors. Despite recent challenges,..

PureTech Health plc (PRTC) Stock Analysis: Exploring the 162% Potential Upside

PureTech Health plc (NASDAQ: PRTC), a biotechnology company with an intriguing mix of advanced therapeutic candidates, is capturing the attention of investors with its significant potential..

SI-BONE, Inc. (SIBN) Stock Analysis: A Medical Device Innovator with 64% Potential Upside

SI-BONE, Inc. (NASDAQ: SIBN), a leading player in the medical devices sector, has emerged as an intriguing investment opportunity for those seeking high growth potential in..

Cel-Sci Corporation (CVM) Stock Analysis: Is the 1,775% Potential Upside Worth the Risk?

In the dynamic and often unpredictable world of biotechnology, Cel-Sci Corporation (NASDAQ: CVM) presents an intriguing proposition for investors seeking high-risk, high-reward opportunities. With a staggering..

InnovAge Holding Corp. (INNV) Stock Analysis: What Investors Need to Know About Its Potential Downside

InnovAge Holding Corp. (NASDAQ: INNV), a prominent player in the healthcare sector, particularly in the medical care facilities industry, offers a unique business model that focuses..

Maze Therapeutics, Inc. (MAZE) Investor Outlook: Strong Buy Ratings and Potential 32.98% Upside

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company based in South San Francisco, California, is making waves in the biotechnology sector with its cutting-edge approach..

Claritev Corporation (CTEV) Stock Analysis: Healthcare Data Leader with 24.71% Upside Potential

Claritev Corporation (NASDAQ: CTEV), a prominent player in the healthcare information services industry, has captured investor attention with its potential upside of 24.71%, based on the..

Upstream Bio, Inc. (UPB) Investor Outlook: Unpacking the 123% Potential Upside in Biotech

Upstream Bio, Inc. (UPB), a promising player in the biotechnology sector, has caught the attention of investors with its impressive growth metrics and significant target price..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 15.8% Upside Potential in the Cannabis Sector

Tilray Brands, Inc. (TLRY), a prominent player in the healthcare sector, is making waves in the specialty and generic drug manufacturing industry. Headquartered in Leamington, Canada,..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a Challenging Landscape with a 44.82% Upside Potential

Cross Country Healthcare, Inc. (NASDAQ: CCRN) operates within the healthcare sector, specifically focusing on medical care facilities. With a market cap of $420.99 million, this Boca..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: A 200% Upside Potential in the Biotech Space

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, is attracting significant attention from investors with its promising pipeline of innovative treatments for autoimmune diseases and..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A 72% Potential Upside Beckons Amid Biotech Innovation

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) has captured the attention of investors with its pioneering work in the biotechnology sector. Specializing in developing complement therapeutics for severe..

Talkspace, Inc. (TALK) Stock Analysis: A 64.95% Upside Potential Amidst Growing Healthcare Demand

Investors with an eye on the healthcare sector may find Talkspace, Inc. (NASDAQ: TALK) an intriguing prospect, particularly given its substantial potential upside of 64.95%, as..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Biotech Player with Remarkable Revenue Growth and Promising Drug Pipeline

Investors keen on the biotechnology sector may find Stoke Therapeutics, Inc. (NASDAQ: STOK) an intriguing company to watch. With its innovative approach to treating severe genetic..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: A 281% Potential Upside on the Horizon

Anavex Life Sciences Corp. (NASDAQ: AVXL) is making waves in the biotechnology sector with its promising pipeline of treatments targeting a range of neurodegenerative and neuropsychiatric..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds